Last updated 7 months ago

A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy

40 patients around the world
Available in United States, Argentina, Brazil
Minoryx Therapeutics, S.L.
2Research sites
40Patients around the world
Requirements for the patient
From 18 Years
Male
Medical requirements
Sites
Hospital Universitario Austral - Pilar
Av. Juan Domingo Perón 1500, Pilar, Buenos Aires
Universidad Federal de São Paulo - Unifesp
R. Sena Madureira, 1500 - Vila Clementino, São Paulo - SP, 04021-001
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy